These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17970045)

  • 1. Iron accumulation in mammary tumor suggests a tug of war between tumor and host for the microelement.
    Freitas I; Boncompagni E; Vaccarone R; Fenoglio C; Barni S; Baronzio GF
    Anticancer Res; 2007; 27(5A):3059-65. PubMed ID: 17970045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC; Springs AE; Chen WY
    Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
    Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A
    Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell recruitment and liver de-differentiation in MMTV-neu (ErbB-2) transgenic mice.
    Freitas I; Fracchiolla S; Baronzio G; Griffini P; Bertone R; Sitar GM; Barni S; Gerzeli G; Sacco MG
    Anticancer Res; 2003; 23(5A):3783-94. PubMed ID: 14666678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS
    Cancer Res; 2002 May; 62(10):2798-805. PubMed ID: 12019156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice.
    Henry MD; Triplett AA; Oh KB; Smith GH; Wagner KU
    Oncogene; 2004 Sep; 23(41):6980-5. PubMed ID: 15286714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells.
    Galiè M; Sorrentino C; Montani M; Micossi L; Di Carlo E; D'Antuono T; Calderan L; Marzola P; Benati D; Merigo F; Orlando F; Smorlesi A; Marchini C; Amici A; Sbarbati A
    Carcinogenesis; 2005 Nov; 26(11):1868-78. PubMed ID: 15975963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.
    Abe F; Dafferner AJ; Donkor M; Westphal SN; Scholar EM; Solheim JC; Singh RK; Hoke TA; Talmadge JE
    Cancer Immunol Immunother; 2010 Jan; 59(1):47-62. PubMed ID: 19449184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
    Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
    Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse mammary tumor virus derived from wild mice does not target Notch-4 protooncogene for the development of mammary tumors in inbred mice.
    Sarkar NH
    Virology; 2009 May; 388(1):121-7. PubMed ID: 19329137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2.
    Davis VL; Jayo MJ; Ho A; Kotlarczyk MP; Hardy ML; Foster WG; Hughes CL
    Cancer Res; 2008 Oct; 68(20):8377-83. PubMed ID: 18922910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
    Cho RW; Wang X; Diehn M; Shedden K; Chen GY; Sherlock G; Gurney A; Lewicki J; Clarke MF
    Stem Cells; 2008 Feb; 26(2):364-71. PubMed ID: 17975224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactive effects of selenium and chromium on mammary tumor development and growth in MMTV-infected female mice and their relevance to human cancer.
    Schrauzer GN
    Biol Trace Elem Res; 2006 Mar; 109(3):281-92. PubMed ID: 16632896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
    Fleming NI; Trivett MK; George J; Slavin JL; Murray WK; Moseley JM; Anderson RL; Thomas DM
    Cancer Res; 2009 Sep; 69(18):7473-9. PubMed ID: 19723659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
    Szabova L; Chrysovergis K; Yamada SS; Holmbeck K
    Oncogene; 2008 May; 27(23):3274-81. PubMed ID: 18071307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selenium and low levels of lead on mammary tumor development and growth in MMTV-infected female mice.
    Schrauzer GN
    Biol Trace Elem Res; 2008 Dec; 125(3):268-75. PubMed ID: 18726561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse.
    Bugelski PJ; Porter CW; Dougherty TJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4606-12. PubMed ID: 7306978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.
    De Giovanni C; Nicoletti G; Landuzzi L; Croci S; Palladini A; Antognoli A; Murgo A; Ianzano ML; Grosso V; Stivani V; Iezzi M; Musiani P; Nanni P; Lollini PL
    Vaccine; 2009 Mar; 27(14):2065-9. PubMed ID: 19428831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.